Patents Assigned to Episcan Global, LLC
  • Patent number: 11089996
    Abstract: Various methods and machines have been used in the past to measure electrical characteristics of living tissue for purpose of locating an area of abnormal nervous system activity. However, whereas prior art methodologies merely allow for the detection of pain, the apparatus, system and method of the present invention allow for the objective assessment pain severity that finds utility not only the initial diagnosis but also the on-going treatment of any disease, disorder or injury associated therewith. To that end, the apparatus, system and method of the present invention allows medical practitioners to non-invasively and quantitatively distinguish organic pain from psychosomatic pain and legitimate pain patients from drug seekers and opiod addicts, as well as to directly and objectively compare the efficacy of different drug regimens and therapy protocols.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: August 17, 2021
    Assignee: Episcan Global, LLC
    Inventors: David Michael Sitton, Christopher P. Dougherty, Samuel F. Arndt, III
  • Publication number: 20210085243
    Abstract: Various methods and machines have been used in the past to measure electrical characteristics of living tissue for purpose of locating an area of abnormal nervous system activity. However, whereas prior art methodologies merely allow for the detection of pain, the apparatus, system and method of the present invention allow for the objective assessment of autonomic nerve function and/or pain severity. As such, the present invention finds utility not only the initial diagnosis, including the early diagnosis of generally asymptomatic autonomic dysfunction, but also the on-going treatment of any disease, disorder or injury associated therewith. To that end, the apparatus, system and method of the present invention allows medical practitioners to non-invasively and quantitatively distinguish the organic from the psychosomatic and legitimate pain patients from drug seekers and opioid addicts, as well as to directly and objectively compare the efficacy of different drug regimens and therapy protocols.
    Type: Application
    Filed: December 14, 2018
    Publication date: March 25, 2021
    Applicant: Episcan Global, LLC
    Inventors: David Michael SITTON, Christopher P. DOUGHERTY, Samuel F. ARNDT, III
  • Publication number: 20180289317
    Abstract: Various methods and machines have been used in the past to measure electrical characteristics of living tissue for purpose of locating an area of abnormal nervous system activity. However, whereas prior art methodologies merely allow for the detection of pain, the apparatus, system and method of the present invention allow for the objective assessment pain severity that finds utility not only the initial diagnosis but also the on-going treatment of any disease, disorder or injury associated therewith. To that end, the apparatus, system and method of the present invention allows medical practitioners to non-invasively and quantitatively distinguish organic pain from psychosomatic pain and legitimate pain patients from drug seekers and opiod addicts, as well as to directly and objectively compare the efficacy of different drug regimens and therapy protocols.
    Type: Application
    Filed: December 14, 2017
    Publication date: October 11, 2018
    Applicant: Episcan Global, LLC
    Inventors: David Michael SITTON, Christopher P. DOUGHERTY, Samuel F. ARNDT, III